Tim Petersen is a Managing Partner at Arboretum Ventures, a healthcare venture capital firm that he co-founded in 2002. Tim focuses on transformative opportunities that disrupt healthcare sectors starved of technology or business model innovation. His investments span a variety of healthcare sectors, including healthcare information technology, medical device, and research instrumentation companies. Examples of Tim’s successful companies include Inogen (Nasdaq: INGN) which revolutionized the delivery of oxygen to COPD patients, and Pear Therapeutics, developer of the country’s first FDA cleared “prescription digital therapeutic.” He also led or co-led the initial venture capital investment into Advanced ICU Care, now the nation’s largest provider of tele-ICU solutions, and Accuri Cytometers, which upended the billion-dollar flow cytometry sector. Other public and exited investments include SI-Bone (Nasdaq: SIBN) and behavioral health technology company HealthMedia, sold to Johnson & Johnson.
Before co-founding Arboretum, Tim helped establish the Zell Lurie Institute (ZLI) for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. The Institute has been consistently ranked as one of the top entrepreneurship programs in the country. He also directed the activities of the Wolverine Venture Fund, which invests in early-stage life science and technology investments. Prior to ZLI, Tim was a manager in the investment banking practice at Plante Moran and served as a management consultant at Industrial Economics in Cambridge, MA. Tim currently serves as an advisory board member for ZLI and the Wolverine Venture Fund. He is also board chair for the University Musical Society, the nation’s oldest university-based presenting arts organization.
Tim holds a BA in Economics from Williams College, an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan.